Skip to main content
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. — Investor Relations & Filings

Ticker · MRKR ISIN · US57055L1070 US Manufacturing
Open in API
Filings indexed 899 across all filing types
Latest filing 2010-06-16 Capital/Financing Update
Country US United States of America
Listing US MRKR

About Marker Therapeutics, Inc.

https://markertherapeutics.com/

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematologic malignancies and solid tumors. The company's core technology is its Multi-Antigen Recognizing (MAR) T cell platform, which utilizes natural, non-genetically modified T cells to recognize and kill heterogeneous tumors. This approach is designed to provide durable anti-tumor responses with a favorable safety profile. Its lead product candidate, MT-601, recognizes six tumor-specific antigens and is being evaluated in a Phase 1 study for patients with lymphoma who have relapsed or are ineligible for anti-CD19 CAR-T cell therapy. The technology was originally developed at Baylor College of Medicine.

Recent filings

Filing Released Lang Actions
FORM S-1
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated June 16, 2010, for TapImmune Inc. It is a registration statement under the Securities Act of 1933, used for registering securities for public offering. The text includes detailed information about the securities being registered, the offering, risk factors, business description, management, and financial statements index. This is a capital markets filing related to fundraising and securities issuance, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual registration statement, not just an announcement of a report, so it is not RPA or RNS. Hence, the correct classification is CAP with high confidence.
2010-06-16 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement (a Technology Option Agreement with Mayo Foundation) and a press release about the licensing option agreement. There are no financial statements or detailed financial data presented, and the document is relatively short (3850 characters). It is an announcement of a material event rather than a full financial report or earnings release. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2010-06-04 English
Regulatory Filings 2010
Regulatory Filings
2010-06-02 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the closing of a financing transaction involving Senior Convertible Notes totaling $1.53 million. It includes a press release about the financing but does not contain detailed financial statements or comprehensive financial analysis. The document is relatively short (2977 characters) and primarily serves as an announcement of a capital raising event. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2010-05-24 English
FORM 10-Q
Interim / Quarterly Report Q1 2010
2010-05-24 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 18, 2010, reporting the entry into a material definitive agreement involving the issuance of Senior Secured Convertible Notes and related warrants. It details the terms of the financing transaction, including the securities purchase agreement, security agreement, registration rights agreement, and compensation to the placement agent. The document also includes a press release about the transaction. The content focuses on a financing update and capital structure change rather than a full financial report or earnings release. Therefore, this filing is best classified as a Capital/Financing Update (CAP). The document length (7945 characters) and detailed transaction terms support this classification with high confidence.
2010-05-18 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.